Atjaunināt sīkdatņu piekrišanu

E-grāmata: Plant-Derived Anticancer Drugs in the OMICS Era: Biosynthesis, Functions, and Applications

Edited by , Edited by
  • Formāts: 322 pages
  • Izdošanas datums: 27-Oct-2023
  • Izdevniecība: Apple Academic Press Inc.
  • Valoda: eng
  • ISBN-13: 9781000852196
  • Formāts - EPUB+DRM
  • Cena: 165,68 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Bibliotēkām
  • Formāts: 322 pages
  • Izdošanas datums: 27-Oct-2023
  • Izdevniecība: Apple Academic Press Inc.
  • Valoda: eng
  • ISBN-13: 9781000852196

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

"The current anti-cancer synthetic medicines are inefficient and unsafe. The plants-based lead molecules such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine and numerous other anticancer compounds from Nature's arsenal are potentially safe and powerful alternative means that effectively fight against cancer. The volume looks at a variety of medicinal plants and approaches that have beneficial results against cancer. Topics include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties. This volume, Plant-Derived Anticancer Drugs in the OMICS Era: Biosynthesis, Function, and Applications, will be valuable to cancer researchers and drug developers among others"--

Looks at medicinal plants and their uses that have beneficial results against cancer. Topics include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance anticancer potential, computational approaches, and more. It also examines the metabolomics of plants that give them anti-cancer properties.



The current anti-cancer synthetic medicines are deemed inefficient and unsafe, state the editors of this new book. Plant-based lead molecules, however, such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine, and numerous other anticancer compounds from nature’s arsenal, are potentially safe and can be powerful alternatives that effectively fight against cancer.

The volume looks at a variety of medicinal plants and approaches that have shown beneficial results against cancer. Topics in the book include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance a plant’s anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties.

1. Evaluation of Extracts from Curcu malonga and Zingiber officinale as Growth Inhibitors of HeLa and HuH-7 Cell Lines
2. Role of Herbal Medicines in Liver Cancer
3. Unani Approaches of Anticancer Plants Against Cancer
4. Exploration of Anticancer Medicinal Plants of Northern Hemisphere
5. Genetic Engineering of Plants for Enhanced Anticancer Potential
6. Genetic Engineering of Plants of Enhancing Secondary Metabolites with Anti-Cancerous Properties
7. Genomics of Plants with Anticancer Properties: Breaking New Ground in Cancer Therapy
8. Metabolomics of Anti-Cancer Plants
9. Computational Approaches Used in Anticancer Plants
10. CRISPR/CAS-Mediated Editing of Anticancer Plants
11. Zinc Finger Nuclease (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs): Based Genome Editing in Enhancement of Anticancer Activity of Plants

Deepu Pandita is a Senior Lecturer in the Government Department of School Education, Jammu, India. She has more than 19 years of teaching experience. She has published editorials, book chapters, reviews, and research articles in journals of national and international repute and also acts as a reviewer, associate editor, and editor of several international journals. She has presented her research at professional conferences and has received awards for her work.

Anu Pandita is a Dietician at Vatsalya Clinic, Krishna Nagar, New Delhi, India. Previously she worked as a lecturer at Bee Enn College of Nursing, Talab Tillo, Jammu, India, and as a Dietician at Ahinsa Dham Bhagwan Mahavir Charitable Health Centre, New Delhi, India. She conducted a case study at the Pediatric Gastroenterology Ward at Nehru Hospital, PGI, Chandigarh, India, on a patient suffering from chronic liver disease. She has published books, book chapters, and research articles in journals of national and international repute and has also presented her research at national and international conferences.

Titles of related interest from Deepu Pandita and Anu Pandita:

Antidiabetic Plants for Drug Discovery: Pharmacology, Secondary Metabolite Profiling,

and Ingredients with Insulin Mimetic Activity

Plant Transposable Elements: Biology and Biotechnology

CRISPR/Cas-Mediated Genome Editing in Plants

Antidiabetic Potential of Plants in the Era of Omics

Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients,

and Pharmacological Outcomes